Literature DB >> 31556476

Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension.

Gülsüm Özkan1, Şükrü Ulusoy2, Elif Geyik3, Yunus Erdem4.   

Abstract

Complex mechanisms including genetic factors have been proposed in the pathogenesis of primary hypertension (HT). Micro RNAs (miRNAs) are single-stranded RNA molecules that are not converted into protein products. However, it has been established that genes regulate conversion into protein products. The primary aim of this study was to investigate the roles of miRNA 4516, miRNA 145, miRNA 24, and miRNA 181a in the pathogenesis of HT. The secondary aim was to investigate the relation between these miRNAs and renin, aldosterone, norepinephrine, renalase, and NOS. Fifty-two hypertensive and 51 control normotensive individuals under observation in the Cappadocia cohort were included in the study. miRNA 4516, miRNA 181a, miRNA 24, and miRNA 145 levels were measured using the ddPCR method. miRNA 4516 and norepinephrine levels were significantly higher in the HT group (P < .005 for both), while miRNA 145 levels were significantly lower (<.05). miRNA 4516 up-regulation (P < .05) and miRNA 145 down-regulation (P < .05) were identified as independent predictors of HT. Renalase exhibited negative correlation with miRNA 4516 and positive correlation with miRNA 145 in the patient and control group. In addition, negative correlation was present between miRNA 24 and NE and NOS and between miRNA 181a and NOS in the patient group. Our study identified, for the first time in the literature, miRNA 4516 up-regulation and miRNA 145 down-regulation as independent determinants of HT. Further studies performed in the light of our findings may lead to a better understanding of the pathogenesis and new therapeutic possibilities. ©2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  hypertension; miRNA 145; miRNA 181a; miRNA 24; miRNA 4516

Mesh:

Substances:

Year:  2019        PMID: 31556476      PMCID: PMC8030420          DOI: 10.1111/jch.13704

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  Role of miR-145 in cardiac myofibroblast differentiation.

Authors:  Yao-Sheng Wang; Shu-Hong Li; Jian Guo; Anton Mihic; Jun Wu; Lu Sun; Kelly Davis; Richard D Weisel; Ren-Ke Li
Journal:  J Mol Cell Cardiol       Date:  2013-08-31       Impact factor: 5.000

Review 2.  microRNA-21 and hypertension.

Authors:  Xiao Li; Yongxiang Wei; Zuoguang Wang
Journal:  Hypertens Res       Date:  2018-07-04       Impact factor: 3.872

3.  Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries.

Authors:  Elena Miotto; Elena Saccenti; Laura Lupini; Elisa Callegari; Massimo Negrini; Manuela Ferracin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

Review 4.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 5.  History of vascular reactivity models and their involvement in hypertension pathogenesis.

Authors:  Ana Gabriela Conceição-Vertamatti; Filipy Borghi; Fernando Canova; Dora Maria Grassi-Kassisse
Journal:  Vasa       Date:  2017-08-31       Impact factor: 1.961

6.  Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

Authors:  Donato Santovito; Claudia Mandolini; Pamela Marcantonio; Velia De Nardis; Marco Bucci; Camilla Paganelli; Francesco Magnacca; Sante Ucchino; Daniela Mastroiacovo; Giovambattista Desideri; Andrea Mezzetti; Francesco Cipollone
Journal:  Expert Opin Ther Targets       Date:  2013-01-23       Impact factor: 6.902

7.  A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice.

Authors:  Kristy L Jackson; Francine Z Marques; Anna M D Watson; Kesia Palma-Rigo; Thu-Phuc Nguyen-Huu; Brian J Morris; Fadi J Charchar; Pamela J Davern; Geoffrey A Head
Journal:  Hypertension       Date:  2013-07-29       Impact factor: 10.190

8.  Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.

Authors:  Markus P Schlaich; Elisabeth Lambert; David M Kaye; Zygmunt Krozowski; Duncan J Campbell; Gavin Lambert; Jacqui Hastings; Anuradha Aggarwal; Murray D Esler
Journal:  Hypertension       Date:  2003-11-10       Impact factor: 10.190

Review 9.  Circulating microRNAs and hypertension--from new insights into blood pressure regulation to biomarkers of cardiovascular risk.

Authors:  Simon P R Romaine; Fadi J Charchar; Nilesh J Samani; Maciej Tomaszewski
Journal:  Curr Opin Pharmacol       Date:  2016-01-28       Impact factor: 5.547

10.  Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension.

Authors:  Gülsüm Özkan; Şükrü Ulusoy; Elif Geyik; Yunus Erdem
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-26       Impact factor: 3.738

View more
  4 in total

1.  Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension.

Authors:  Gülsüm Özkan; Şükrü Ulusoy; Elif Geyik; Yunus Erdem
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-26       Impact factor: 3.738

2.  MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone.

Authors:  Sonat Pınar Kara; Gulsum Ozkan; Ahsen Yılmaz; Nergiz Bayrakçı; Savaş Güzel; Elif Geyik
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

3.  Analysis of nocturnal, hypoxia-induced miRNAs in sleep apnea patients.

Authors:  Philip Roger Goody; Lisa Nachtsheim; Mohammed Rabiul Hosen; Miriam von Krosigk; Dominik Christmann; Jens Peter Klussmann; Andreas Zietzer; Nils Breitrück; Felix Jansen; Stefanie Jansen
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

4.  MicroRNA Profiles in Normotensive and Hypertensive South African Individuals.

Authors:  Don M Matshazi; Cecil J Weale; Rajiv T Erasmus; Andre P Kengne; Saarah F G Davids; Shanel Raghubeer; Stanton Hector; Glenda M Davison; Tandi E Matsha
Journal:  Front Cardiovasc Med       Date:  2021-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.